Quarry Thera, a next-generation brachytherapy innovator, is advancing brachytherapy using molecular-glue technology.
Quarry Thera has raised $32.0M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
Quarry Thera's investors include Yosemite, F-Prime, Canaan Partners, Lilly Ventures.
Quarry Thera is headquartered in New Haven, United States.
Quarry Thera, a next-generation brachytherapy innovator, is advancing brachytherapy using molecular-glue technology.
Quarry Thera is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quarry Thera — Funding & Investors." VCBacked, November 26, 2025, https://www.vcbacked.co/company/quarry-thera. Accessed August 15, 2026.
VCBacked. (2025). Quarry Thera — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/quarry-thera
{{cite web |title=Quarry Thera — Funding & Investors |url=https://www.vcbacked.co/company/quarry-thera |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated